Literature DB >> 9450511

Measuring dopamine transporter occupancy by cocaine in vivo: radiotracer considerations.

J S Fowler1, N D Volkow, J Logan, S J Gatley, N Pappas, P King, Y S Ding, G J Wang.   

Abstract

Several recent neuroimaging studies in humans and in monkeys using different radiotracers have reported widely differing values of dopamine transporter (DAT) occupancy by doses of cocaine which are perceived as reinforcing by humans. Here we tested the hypothesis that the measurement of DAT occupancies by drugs with fast pharmacokinetics such as cocaine requires a radioligand with similar kinetics in order to effectively compete with the drug. We measured DAT occupancy by four different doses of cocaine (1.0, 0.5, 0.25, and 0.1 mg/kg) using [11C]d-threo-methylphenidate (a radiotracer which binds rapidly to the DAT in vivo) and compared them to estimates reported previously using [11C]cocaine in the same two baboons and with the same four doses of cocaine [Volkow et al. (1996b) Synapse 24:399-402). Cocaine reduced [11C]d-threo-methylphenidate binding in striatum in a dose-dependent manner, and values were significantly correlated with those obtained previously with [11C]cocaine (r = 0.9, F = 37, P < 0.001). The ED50s (50% occupancy of DAT by cocaine) were 0.27 and 0.17 mg/kg for [11C]d-threo-methylphenidate and [11C]cocaine, respectively. This is significantly lower than values obtained with labeled beta-CIT and other similar radiotracers with a slow uptake and clearance (ED50s: 3-7 mg/kg). We conclude that in vivo measurements of DAT occupancy by rapidly clearing drugs like cocaine requires the use of radiotracers having similar kinetics to the drug itself.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9450511     DOI: 10.1002/(SICI)1098-2396(199802)28:2<111::AID-SYN1>3.0.CO;2-E

Source DB:  PubMed          Journal:  Synapse        ISSN: 0887-4476            Impact factor:   2.562


  24 in total

1.  Brain temperature change and movement activation induced by intravenous cocaine delivered at various injection speeds in rats.

Authors:  P Leon Brown; Eugene A Kiyatkin
Journal:  Psychopharmacology (Berl)       Date:  2005-10-14       Impact factor: 4.530

2.  The role of peripheral and central sodium channels in mediating brain temperature fluctuations induced by intravenous cocaine.

Authors:  Eugene A Kiyatkin; P Leon Brown
Journal:  Brain Res       Date:  2006-09-07       Impact factor: 3.252

3.  Cocaine disinhibits dopamine neurons in the ventral tegmental area via use-dependent blockade of GABA neuron voltage-sensitive sodium channels.

Authors:  Scott C Steffensen; Seth R Taylor; Malia L Horton; Elise N Barber; Laura T Lyle; Sarah H Stobbs; David W Allison
Journal:  Eur J Neurosci       Date:  2008-11       Impact factor: 3.386

4.  Seeing how we smell.

Authors:  Helene Benveniste; Yuri Lazebnik; Nora D Volkow
Journal:  J Clin Invest       Date:  2017-01-23       Impact factor: 14.808

5.  Conserved dorsal-ventral gradient of dopamine release and uptake rate in mice, rats and rhesus macaques.

Authors:  Erin S Calipari; Kimberly N Huggins; Tiffany A Mathews; Sara R Jones
Journal:  Neurochem Int       Date:  2012-07-20       Impact factor: 3.921

Review 6.  Development of the dopamine transporter selective RTI-336 as a pharmacotherapy for cocaine abuse.

Authors:  F Ivy Carroll; James L Howard; Leonard L Howell; Barbara S Fox; Michael J Kuhar
Journal:  AAPS J       Date:  2006-03-24       Impact factor: 4.009

Review 7.  Tactics for preclinical validation of receptor-binding radiotracers.

Authors:  Susan Z Lever; Kuo-Hsien Fan; John R Lever
Journal:  Nucl Med Biol       Date:  2016-09-03       Impact factor: 2.408

8.  Cocaine occupancy of sigma1 receptors and dopamine transporters in mice.

Authors:  John R Lever; Emily A Fergason-Cantrell; Lisa D Watkinson; Terry L Carmack; Sarah A Lord; Rong Xu; Dennis K Miller; Susan Z Lever
Journal:  Synapse       Date:  2015-12-24       Impact factor: 2.562

9.  Phasic and tonic fluctuations in brain, muscle, and skin temperatures during motivated drinking behavior in rats: physiological correlates of motivation and reward.

Authors:  Michael S Smirnov; Eugene A Kiyatkin
Journal:  Brain Res       Date:  2009-11-22       Impact factor: 3.252

10.  Dexmethylphenidate hydrochloride in the treatment of attention deficit hyperactivity disorder.

Authors:  Feng Liu; Haruka Minami; Raul R Silva
Journal:  Neuropsychiatr Dis Treat       Date:  2006-12       Impact factor: 2.570

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.